ERIN PRICE: Open Payments
NPI 1346547569 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 33 payments from 12 companies in 2025. Trend: 2023 $291 · 2024 $715 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $232 |
| Novo Nordisk Inc | 7 | $144 |
| ABBVIE INC. | 4 | $83 |
| Axsome Therapeutics, Inc. | 2 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: AIRSUPRA, Ozempic, Symbravo, BREZTRI, UBRELVY, FARXIGA, XIFAXAN, JARDIANCE.
Industry payments across GA — which companies pay providers there.
